{"name":"Delta-Fly Pharma, Inc.","slug":"delta-fly-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"DFP-10917","genericName":"DFP-10917","slug":"dfp-10917","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"DFP-10917","genericName":"DFP-10917","slug":"dfp-10917","phase":"phase_3","mechanism":"DFP-10917 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOFQ0d0lKOHNHTjhEU3M5Sy05MnRCU1ZRaUp4VTVreXFaMzF0aFN0TXUzd2lxbE9lcjNHZkxJS1Jxc2stYVhoN1NhR2pVaEFyRnZoWWpHZUN6eUV3YkxPV2k3bTdRZGRIN2hnRkIxTjYwWm1ZQ3lNT0NEWEhoblBrZUxtRU12WVJlbVplcXUzSktqdThyaFdCT0g2Z2wzbXlYdm1DdUt6MVNSUlpFOHdDM0xWY29xUWwzc2lWd2RneGFhQQ?oc=5","date":"2026-03-26","type":"trial","source":"marketscreener.com","summary":"Delta-Fly Pharma Corrects Drug Trial Data to Include Partial Remissions - marketscreener.com","headline":"Delta-Fly Pharma Corrects Drug Trial Data to Include Partial Remissions","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQM0JaVzhUX3hTME5WOWdCRF9kTkNlS0RfYmN6OU4xSVZ1VmJoRmNRTFNFTXhIVEZlb1kwRG8yR3JfdkVTb0tvQUkzVnc3ckthR0czbEQtMXQyb2JoRWVWNzJ3M3B0RVV4YnUzbFZ4bDZnbGh0R1R0OUhmQ1JPR2J5ZU1CUlRVVUpSTkJyNFRROGljankxMEVNOHl0dVhRbzNZSmpleG5DT3RqMmpOM0hETjR1OTZaRVdjRjRyNVJpelM0R3Zoa0pwZnlwVWplLVZrWTlyaXJn?oc=5","date":"2026-01-30","type":"pipeline","source":"The Delta News","summary":"Pharmaceutical company to invest $3.5 billion in Pa. - The Delta News","headline":"Pharmaceutical company to invest $3.5 billion in Pa.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOLVNuYlZKejc2LTZvamJhREpVOUx6MmJ6QWVPcWdnTW44MlFQNklwY3F0b1g4NmlZVkhDU2NBTmhYamxGVFJBN1NybnVIblhxSlJaMGJwTTJQQnJuX2xWZnRINlJxdXlGd3l3R0k2UFNzSlc5WVNnXzF3M3poWEZNMXFWc3R0elUyWlE0bDhiNk44N1p4b0RvNFc2NFBEMmJhcjJ5U19EYmdKV0dTZU5Gek13?oc=5","date":"2026-01-22","type":"pipeline","source":"BioWorld News","summary":"Rezubio Pharmaceuticals discloses new drug conjugates to treat fibrosis - BioWorld News","headline":"Rezubio Pharmaceuticals discloses new drug conjugates to treat fibrosis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPbERHNHdXMVo5QURlYU5fWi03bnJNckItRktnVncyZ05DTC1JbndMeEhUME1KdU90NWtBX18wcHg1dzJfdEI4Y1gzd01HczBOM04tRjRyZDBDMzZfa2Y4OEJwc1hPOWM1Q3dDNmktbDc4LXRMNER1TXliQmRWa1NSTFAzWUNGZ0M2S1NRSU1LenVVNVZpTVA5bTBvYk9HcnRiblczRjVjbDN5WTFlcXVmN0dRQ2lGd1FvNWhRQUdqZXpSU2hzU2ZuMG9POHRWQQ?oc=5","date":"2025-12-04","type":"pipeline","source":"Balkanweb.com","summary":"SPAK investigations reveal Ilir Beqaj's maneuver, how he favored the pharmaceutical company \"Delta Pharma\" - Balkanweb.com","headline":"SPAK investigations reveal Ilir Beqaj's maneuver, how he favored the pharmaceutical company \"Delta Pharma\"","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOSkFrMFRtNWlKXzVDRXVMOHJxNUpfeDNZN3dBWFFZRWJUYXVHdEJzOExTQnZuN1J3UnItQkhkU00zWDZoeUEtdjJCSms1UE5IUmI2MW5FOVVwNGF4Y19IdTJPRkg1bVVLQ1FpUTE5QUVrX01UQ2JBdnZFaFFvejlkUHluX3pXQWVoX1BNMEF1M0RxTmlXSXN5cg?oc=5","date":"2025-10-28","type":"pipeline","source":"Ad Age","summary":"15 agency reviews to know about: Amex, Bayer, Delta, Takis - Ad Age","headline":"15 agency reviews to know about: Amex, Bayer, Delta, Takis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1Hc2NxWWpKZU9jc0NBVkIwSDNTSGI3ZGticDk2UUZFN1JyTFFUV0Z4ZXJCRE9fSXp2cERmTC1JcnVOQ2tWazNvX0xPS2xJcnkzYk4zdk9SX3FJa3psNkhwZE1pNmlSLVNDRUkydTZIdnJYakRDNjVxMWhWMA?oc=5","date":"2025-08-07","type":"pipeline","source":"Wiley","summary":"Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia - Wiley","headline":"Contemporary outcomes of octa-nonagenarians with newly diagnosed acute myeloid leukemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxPV1lFZFBJRTc2UGhsallqajFaVTBycEhab1JxTWdkc1VmOGMycWJLdkstbXNTM0c0YWpxX0E1ajdxZDZCNEwtOXBpVVV5VVNqa2JybThTbTVSNmJ3blh5RkdPR0lOR2tyUXBTYVZaa1htQUhEbTNhbWFtcVBtNklVRldHYm9Odm5HaU5fNHhSS2JPbGc1ZEZIS3d1REpXNkNzRkd0TnBDak1LYUtTaWVWMVI1UUVZQ3BQazVFM1B1RGJsby10YUpfdlVxa1ZMc3hZVjNvUmg0NHgxLUZyeTJwODRyQ1hFeDJ4VllsWFhTOTBrOEhMZUtSVXBYamxRMkN0b3pqN05tNmFkbmQzeDNDNE9mTWtDaWN3Y0tnMnNnY1Q0SlM2aTBFY0ZVU1lwSFQ1SVQ2cE5ORXp1bnBwY0V2cw?oc=5","date":"2025-07-15","type":"regulatory","source":"PR Newswire","summary":"Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight - PR Newswire","headline":"Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxPMHhVOUJLdlNuMkcxSEotNndNLVhtSWRLdDZYaC1odUstLWd3SEdrMVAzV0JaLVA0QWJONkVxZlg4NWlCNUR4ZkJLRGFPVF9kd0s3TlVYYnlQOWluWklWUDUzRHJ1Nmo2cEEzQ1VGYVVvaElsX0NEbmF6aVB1WDZscTU4RlhvckprSmh5a21GQXBramxYYmtOYlJTSU1QSGtEWUhObTB5ME0xT0FaTEZvdFRrd2xtWjl5ZGc1MjZ4ajkzSG92RVNnT1B1N2NPWjlrUExRdlBMUFU?oc=5","date":"2025-07-11","type":"deal","source":"Stocktwits","summary":"CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled - Stocktwits","headline":"CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNMXBfb05SMWlJXy1lNGQyd3ctTUxZMDA1Y01EX0kxcTlnNnNudGRaSzR3cUdSTUJpVGltTXg5QmlvNHpRdUhrY0NDcmFZLU42TElYXy00Z0Q1YWkyb0tGUFFxd3NFbTV4WGZiYW8xRnJ4aVdlVlJlOUhyUGNoTDgzei1ZSEJEV0hoZTE3eUFhS0h2REJ5V0w0TmZKRWc1WDFZcDRZS3ZFTzYzZzAtYnJVbzFtR1Uydk5RcHJDLVZ3?oc=5","date":"2024-11-26","type":"trial","source":"BioSpace","summary":"Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323 - BioSpace","headline":"Delta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQzdzcmt5amtPeFNWc3hYWHdmYncyZUdPS1FkTDh6emVQRUNKdWgwbmdidDladjk2VHA1dWRPWlhMTjRMQTVyS1R6YmNBalFOaTF6Y1oxRTVOVEFfQnQ4Qkt6NWdrdjZ2VldaanA4eUJqZWdRU0pmQjdFZFdpWTVvVHNnSnBXZGpZWFc1cmRGTHRZMnJuOUphWkh1dFNCVmkxSE1oZXl4SXR1Mk0?oc=5","date":"2024-11-05","type":"trial","source":"BioSpace","summary":"Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927 - BioSpace","headline":"Delta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNTEd1NHhiejlxMGhXTUZSSG0wUVliTnVUZ29QeWduR3ZoRHhBdV96NkZqRTZncUNiRU5tSUJQeDkwWnFsQ0luNjlsS1dYRGxLRDQ2Uno0Nld0TGhpWjByZG1HcTljeDBYUW9XWG9YU2dINE0zNHZ6Tk82R0V6bURocGdzd0JHVUItLUFqWjE5VTFvVUloYzZiLVZnUkFIOWNQWmlIcHllUmRGSjNKeUFJ?oc=5","date":"2024-02-02","type":"trial","source":"Clinical Trials Arena","summary":"Delta-Fly starts Phase III trial for NSCLC adjuvant therapy in Japan - Clinical Trials Arena","headline":"Delta-Fly starts Phase III trial for NSCLC adjuvant therapy in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNQ1JhUDNScFMyTUhENmMzdk11UUd3U0R6LTNMMGFTTHRHbXptaGg5SGxfemNsV0NlTzFPV0otd1VDSG04U3lUaWhKSjJUM1V0T2JMVkFCOW1mRVI0Y1ZMdEVTcGh5X3ZYRVdGY2prTUxEemkyN1ljVHNqeHNGdjZkZlFpN05lVVZwU0VCUVhLTWY4ejFIMXFXeFpYOWVxcXJ5RlRaNmFfOWFucVB6d3BtbGg3MmRJYUlnRDgxN2E1d2NhNmYyWmxJRkhieTFsTzRadDVVOGViZXlMalFJTDQ0V0k4M3NFNDRrSlBBNQ?oc=5","date":"2024-01-06","type":"deal","source":"PharmaTimes","summary":"FlyPharma Conference Europe 2023 shares industry collaboration initiatives and explores the future of pharma logistics - PharmaTimes","headline":"FlyPharma Conference Europe 2023 shares industry collaboration initiatives and explores the future of pharma logistics","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}